New combo vaccine study shows promise for protecting babies from meningitis
NCT ID NCT03621670
First seen Feb 12, 2026 · Last updated Apr 29, 2026 · Updated 14 times
Summary
This study looked at whether a meningitis B vaccine (Bexsero) is safe and works well when given alongside a pneumonia vaccine and other routine baby shots. About 1,200 healthy infants aged 6 to 12 weeks took part. Researchers checked for side effects like pain, redness, fever, and fussiness, and measured immune responses to see if the vaccines triggered protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIONS, MENINGOCOCCAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Birmingham, Alabama, 35205, United States
-
GSK Investigational Site
Fayetteville, Arkansas, 72703, United States
-
GSK Investigational Site
Jonesboro, Arkansas, 72401, United States
-
GSK Investigational Site
Anaheim, California, 92804, United States
-
GSK Investigational Site
Oakland, California, 94611, United States
-
GSK Investigational Site
Roseville, California, 95661, United States
-
GSK Investigational Site
Walnut Creek, California, 94596, United States
-
GSK Investigational Site
West Covina, California, 91790, United States
-
GSK Investigational Site
Lake Mary, Florida, 32746, United States
-
GSK Investigational Site
Miami, Florida, 33142, United States
-
GSK Investigational Site
Tampa, Florida, 33613, United States
-
GSK Investigational Site
Nampa, Idaho, 83686, United States
-
GSK Investigational Site
Nampa, Idaho, 83702, United States
-
GSK Investigational Site
Newton, Kansas, 67114, United States
-
GSK Investigational Site
Topeka, Kansas, 66604, United States
-
GSK Investigational Site
Bardstown, Kentucky, 40004, United States
-
GSK Investigational Site
Louisville, Kentucky, 40202, United States
-
GSK Investigational Site
Louisville, Kentucky, 40207, United States
-
GSK Investigational Site
Louisville, Kentucky, 40291, United States
-
GSK Investigational Site
Baltimore, Maryland, 21021, United States
-
GSK Investigational Site
Fall River, Massachusetts, 02721, United States
-
GSK Investigational Site
Bingham Farms, Michigan, 48025, United States
-
GSK Investigational Site
Kansas City, Missouri, 64108, United States
-
GSK Investigational Site
Lincoln, Nebraska, 68516, United States
-
GSK Investigational Site
Omaha, Nebraska, 68128, United States
-
GSK Investigational Site
Liverpool, New York, 13090, United States
-
GSK Investigational Site
Syracuse, New York, 13210, United States
-
GSK Investigational Site
Boone, North Carolina, 28607, United States
-
GSK Investigational Site
Raleigh, North Carolina, 27609, United States
-
GSK Investigational Site
Cincinnati, Ohio, 45245, United States
-
GSK Investigational Site
Dayton, Ohio, 45406, United States
-
GSK Investigational Site
Dayton, Ohio, 45414, United States
-
GSK Investigational Site
Fairfield, Ohio, 45014, United States
-
GSK Investigational Site
South Euclid, Ohio, 44121, United States
-
GSK Investigational Site
Hermitage, Pennsylvania, 16148, United States
-
GSK Investigational Site
Pittsburgh, Pennsylvania, 15224, United States
-
GSK Investigational Site
Charleston, South Carolina, 29406, United States
-
GSK Investigational Site
Sioux Falls, South Dakota, 57105, United States
-
GSK Investigational Site
Clarksville, Tennessee, 37040, United States
-
GSK Investigational Site
Kingsport, Tennessee, 37660, United States
-
GSK Investigational Site
Beaumont, Texas, 77706, United States
-
GSK Investigational Site
Bryan, Texas, 77802, United States
-
GSK Investigational Site
Edinburg, Texas, 78504, United States
-
GSK Investigational Site
Houston, Texas, 77065, United States
-
GSK Investigational Site
Houston, Texas, 77090, United States
-
GSK Investigational Site
San Antonio, Texas, 78229, United States
-
GSK Investigational Site
San Antonio, Texas, 78244, United States
-
GSK Investigational Site
Layton, Utah, 84041, United States
-
GSK Investigational Site
Orem, Utah, 84057, United States
-
GSK Investigational Site
Provo, Utah, 84604, United States
-
GSK Investigational Site
Roy, Utah, 84067, United States
-
GSK Investigational Site
Salt Lake City, Utah, 84121, United States
-
GSK Investigational Site
Syracuse, Utah, 84075, United States
-
GSK Investigational Site
Richmond, Virginia, 23298, United States
-
GSK Investigational Site
Spokane, Washington, 99202, United States
-
GSK Investigational Site
Marshfield, Wisconsin, 54449, United States
-
GSK Investigational Site
San Juan, 00907, Puerto Rico
Conditions
Explore the condition pages connected to this study.